Search research articles
Contact Us
Filters
Showing results (31-40 of 57) with videos related to
Page
of 6
Sort By:
Journal of Clinical Medicine
|
June 18, 2020
Should We Perform Old-for-Old Kidney Transplantation during the COVID-19 Pandemic? The Risk for Post-Operative Intensive Stay
Philip Zeuschner, Urban Sester, Michael Stöckle, et al.
World Journal of Urology
|
April 17, 2024
Multicenter evaluation of complex urinary diversion for renal transplantation: outcomes of complex surgical solutions
Luka Flegar, Johannes Huber, Juliane Putz, et al.
Annals of Surgical Oncology
|
July 5, 2019
4-miRNA Score Predicts the Individual Metastatic Risk of Renal Cell Carcinoma Patients
Joana Heinzelmann, Madeleine Arndt, Ramona Pleyers, et al.
Scientific Reports
|
August 25, 2016
Comparison of different normalization strategies for the analysis of glomerular microRNAs in IgA nephropathy
Clemens L Bockmeyer, Karen Säuberlich, Juliane Wittig, et al.
Urologia Internationalis
|
February 14, 2022
Comparison of First-Line Anti-PD-1-Based Combination Therapies in Metastatic Renal-Cell Carcinoma: Real-World Experiences from a Retrospective, Multi-Institutional Cohort
Benedikt Hoeh, Philipp Schmucker, Niklas Klümper, et al.
Clinical & Translational Immunology
|
December 20, 2021
C-reactive protein flare-response predicts long-term efficacy to first-line anti-PD-1-based combination therapy in metastatic renal cell carcinoma
Niklas Klümper, Philipp Schmucker, Oliver Hahn, et al.
European Urology Open Science
|
August 23, 2024
Radical Prostatectomy in Kidney Transplant Recipients-A Multicenter Experience
Jacob Schmidt, Abdulbaki Yakac, Robert Peters, et al.
Urologic Oncology
|
May 20, 2025
Metastatic renal cell carcinoma: Synchronous vs. metachronous metastatic disease and its impact on cancer control in the IO-combination era-Real world experiences from a multi-institutional cohort
Benedikt Hoeh, Cristina Cano Garcia, Angelika Mattigk, et al.
Clinical Genitourinary Cancer
|
June 2, 2024
First-Line Immune Combination Therapies for Nonclear Cell Versus Clear Cell Metastatic Renal Cell Carcinoma: Real-World Multicenter Data From Germany
Cristina Cano Garcia, Benedikt Hoeh, Subhajit Mandal, et al.
Urologia Internationalis
|
December 24, 2024
Adjuvant Therapy with Pembrolizumab in Renal Cell Carcinoma: Real-World Experiences from a Retrospective, Multi-Institutional Cohort
Angelika Mattigk, Cristina Cano Garcia, Niklas Klümper, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 57) with videos related to
Sort By:
Page
of 6
Journal of Clinical Medicine
|
June 18, 2020
Should We Perform Old-for-Old Kidney Transplantation during the COVID-19 Pandemic? The Risk for Post-Operative Intensive Stay
Philip Zeuschner, Urban Sester, Michael Stöckle, et al.
World Journal of Urology
|
April 17, 2024
Multicenter evaluation of complex urinary diversion for renal transplantation: outcomes of complex surgical solutions
Luka Flegar, Johannes Huber, Juliane Putz, et al.
Annals of Surgical Oncology
|
July 5, 2019
4-miRNA Score Predicts the Individual Metastatic Risk of Renal Cell Carcinoma Patients
Joana Heinzelmann, Madeleine Arndt, Ramona Pleyers, et al.
Scientific Reports
|
August 25, 2016
Comparison of different normalization strategies for the analysis of glomerular microRNAs in IgA nephropathy
Clemens L Bockmeyer, Karen Säuberlich, Juliane Wittig, et al.
Urologia Internationalis
|
February 14, 2022
Comparison of First-Line Anti-PD-1-Based Combination Therapies in Metastatic Renal-Cell Carcinoma: Real-World Experiences from a Retrospective, Multi-Institutional Cohort
Benedikt Hoeh, Philipp Schmucker, Niklas Klümper, et al.
Clinical & Translational Immunology
|
December 20, 2021
C-reactive protein flare-response predicts long-term efficacy to first-line anti-PD-1-based combination therapy in metastatic renal cell carcinoma
Niklas Klümper, Philipp Schmucker, Oliver Hahn, et al.
European Urology Open Science
|
August 23, 2024
Radical Prostatectomy in Kidney Transplant Recipients-A Multicenter Experience
Jacob Schmidt, Abdulbaki Yakac, Robert Peters, et al.
Urologic Oncology
|
May 20, 2025
Metastatic renal cell carcinoma: Synchronous vs. metachronous metastatic disease and its impact on cancer control in the IO-combination era-Real world experiences from a multi-institutional cohort
Benedikt Hoeh, Cristina Cano Garcia, Angelika Mattigk, et al.
Clinical Genitourinary Cancer
|
June 2, 2024
First-Line Immune Combination Therapies for Nonclear Cell Versus Clear Cell Metastatic Renal Cell Carcinoma: Real-World Multicenter Data From Germany
Cristina Cano Garcia, Benedikt Hoeh, Subhajit Mandal, et al.
Urologia Internationalis
|
December 24, 2024
Adjuvant Therapy with Pembrolizumab in Renal Cell Carcinoma: Real-World Experiences from a Retrospective, Multi-Institutional Cohort
Angelika Mattigk, Cristina Cano Garcia, Niklas Klümper, et al.
Page
of 6